Navigation Links
Artificial retina receives FDA approval
Date:2/14/2013

nced semiconductor technology, the engine for the artificial retina is a 'system on a chip' of mixed voltages and mixed analog-digital design, which provides self-contained power and data management and other functionality. This design for the artificial retina facilitates both surgical procedures and regulatory compliance."

The Argus II design consists of an external video camera system matched to the implanted retinal stimulator, which contains a microelectrode array that spans 20 degrees of visual field. The NSF BMES ERC has developed a prototype system with an array of more than 15 times as many electrodes and an ultra-miniature video camera that can be implanted in the eye. However, this prototype is many years away from being available for patient use.

"The external camera system-built into a pair of glasses-streams video to a belt-worn computer, which converts the video into stimulus commands for the implant," says Weiland. "The belt-worn computer encodes the commands into a wireless signal that is transmitted to the implant, which has the necessary electronics to receive and decode both wireless power and data. Based on those data, the implant stimulates the retina with small electrical pulses. The electronics are hermetically packaged and the electrical stimulus is delivered to the retina via a microelectrode array."

In 1998, Robert Greenberg founded Second Sight to develop the technology for the marketplace. While under development, the Argus I and Argus II systems have won wide recognition, including a 2010 Popular Mechanics Breakthrough Award and a 2009 R&D 100 Award, but it is only with FDA approval that the technology can now be made available to patients.

"An artificial retina can offer hope to those with retinitis pigmentosa, as it may help them achieve a level of visual perception that enhances their quality of life, enabling them to perform functions of daily living more easily and the chance to enjoy simple plea
'/>"/>

Contact: Joshua A. Chamot
jchamot@nsf.gov
703-292-7730
National Science Foundation
Source:Eurekalert  

0

GOOD

Page: 1 2 3 4 5

Related biology news :

1. Artificial womb unlocks secrets of early embryo development
2. Artificial wetlands can provide benefits over the long haul
3. UCSF artificial kidney project tapped for accelerated FDA program
4. Liquid glucagon formulation discovered for potential use in artificial pancreas systems
5. Artificial jellyfish swims in a heartbeat
6. UD partner in NIH research project to produce artificial salivary glands
7. Artificial intelligence helps detect subtle differences in mutant worms
8. Researchers develop method to grow artificial tissues with embedded nanoscale sensors
9. High-speed video and artificial flowers shed light on mysteries of hummingbird-pollinated flowers
10. New geometries: Researchers create new shapes of artificial microcompartments
11. Scale-up of a temporary bioartificial liver support system described in BioResearch Open Access
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial retina receives FDA approval
(Date:6/17/2013)... the concept of improving original foundations with more modern ... University of Pittsburgh,s Kenneth P. Dietrich School of Arts ... could make drug delivery, gas storage, and gas transport ... were reported in the latest issue of the ... ). , The recent work builds upon Pitt Associate ...
(Date:6/17/2013)... SAN FRANCISCO-- Vitamin D supplementation may help delay early ... finds. The results were presented Monday at The Endocrine ... girls, puberty generally begins between the ages of 10 ... 12 to 16 years of age. Precocious puberty is ... age of 8; in boys, it is diagnosed when ...
(Date:6/17/2013)... State University research associate has received a prestigious fellowship ... prevent the spread of malaria. , Bart Bryant, research ... Health,s National Research Service Award Individual Postdoctoral Fellowship, which ... Kansas State University researcher to receive the award and ... such an award. , Bryant, a university doctoral graduate ...
Breaking Biology News(10 mins):'Chemical architects' build materials with potential applications in drug delivery and gas storage 2Vitamin D supplementation may delay precocious puberty in girls 2NIH fellowship helps researcher fight malaria, understand mosquito immunity 2
... DALLAS May 11, 2010 Microbiologists at UT Southwestern ... a potential target in cattle that could be exploited to ... strain of Escherichia coli . In the ... Proceedings of the National Academy of Sciences , researchers ...
... is not the only vehicle that can be propelled electrically. ... Mikel Lejarza, Jose Ignacio Uriarte, Miguel ngel Gmez Solaetxe and ... on an innovative project: to have a sailing boat that ... electric energy obtained from the movement of the wind in ...
... 2010) -- Cell-cell junctions are multi-molecular complexes that ... as barriers to permeability, and allow intercellular transport. ... Spring Harbor Laboratory Press, surveys current research on cell ... University) and W. James Nelson (Stanford University), both leaders ...
Cached Biology News:UT Southwestern researchers find mechanism that may stop E. coli from developing in cattle 2Project for sailing vessels to maneuver in ports using electric energy from wind 2Project for sailing vessels to maneuver in ports using electric energy from wind 3
(Date:6/19/2013)... (PRWEB) June 19, 2013 Applied Rigaku ... report that details the measurement of sulfur in ultra-low ... QC+ high resolution benchtop EDXRF analyzer . The analysis ... test method ISO 13032. This International Standard specifies ... the determination of sulfur content in automotive gasoline. , ...
(Date:6/19/2013)... June 18, 2013 A new look ... costs and other trends will highlight technical sessions at ... this fall. In its 33rd year, the three-day event ... exhibition of key suppliers, approximately 100 technical presentations and ... the international society for optics and photonics , the ...
(Date:6/19/2013)... Earth, MN (PRWEB) June 19, 2013 ... of abuse tests, today announced that it has received ... to market and sell its DrugCheck® NxStep Onsite ... allows use of the rapid screening device in near-patient ... Onsite Drug Screen Cup received Health Canada Class III ...
(Date:6/19/2013)... Adding to their already extensive supply ... Simport’s Dropette® and Heathrow Scientific disposable plastic ... basic biology, chemistry and any type of liquid handling ... 35 years, Simport has been supplying the science community ... the Simport Dropette®. Simport’s Dropette® is a one-piece ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2
... 25 Celator Pharmaceuticals today announced that Scott Jackson, chief ... Piper Jaffray Health Care Conference in New York and the ... provide a corporate overview and an update on the company,s ... follows: , , ...
... 25 AngioGenex, Inc. (OTC Bulletin Board: AGGX) is a ... and proteins for the discovery and development of anti-angiogenic drugs ... 2008 objectives and its key business goals for 2009. , ... of important milestones that it set for itself in 2008. ...
... today announced that data from its phase 1/2 clinical ... highlighted in an oral presentation at the 50th Annual ... San Francisco, California, on December 9, 2008. , ... the XIAP Antisense Oligonucleotide (AEG35156) in Combination with Idarubicin ...
Cached Biology Technology:Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference 2AngioGenex Reviews 2008 Achievements and Sets Goals for 2009 2AngioGenex Reviews 2008 Achievements and Sets Goals for 2009 3Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 2Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 3
...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
... UltraMount Plus is formulated for covering tissue ... producing alcohol soluble OR alcohol insoluble end products. ... chromogens such as Fast Red or AEC that ... do not, such as DAB. No heating is ...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Biology Products: